Synergy IB Investment
VC Fund
Seoul, South Korea
Synergy IB Investment is a VC fund in Seoul focused on Health Care and Biotechnology. Synergy IB Investment specializes in the fields of cost, profitability, analysis, finance, and management.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Synergy IB Investment invests in
Stages Synergy IB Investment invests in
Countries Synergy IB Investment invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $6.2M–$8.9M
- Series B
- $12k–$15M
Investment Focus
Industry
- Health Care 7 (39%)
- Biotechnology 5 (28%)
- Pharmaceutical 4 (22%)
- Software 2 (11%)
- E-Commerce 2 (11%)
Stage
- Seed 6 (33%)
- Series B 6 (33%)
- Series A 3 (17%)
- Angel 1 (6%)
- Post-IPO Debt 1 (6%)
Country
- South Korea 12 (67%)
- United States 2 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jeong Ahn-sik
CEO
|
CEO | Total investments: 0 | Find email | |
tae-hoon Koo (Kurt)
Director
|
Director | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Fixup Health provides remote monitoring software that allows rehabilitation therapists to easily provide rehabilitation treatment programs to patients, monitor them, and even file insurance claims | Seed / Dec 17, 2025 | ||
| Creas F&C is a global sports company that produces golf wear and goods. They allow consumers to directly buy goods or services from a seller over the internet. | $21.9M / Post-IPO Debt / Aug 05, 2024 | ||
| Testbank uses artificial intelligence to create interactive reference books. Testbank is the operator of the digital reference book service 'Solve.' Solve is a service that provides reference books and workbooks in paper format suitable for a digital learning environment. | $1.8M / Seed / Mar 13, 2024 | ||
| RnH-Bio is a biotechnology company focused on exosome-based healthcare and regenerative solutions for skincare, beauty, health supplements, and companion animal healthcare. The company develops bio-healthcare products using exosome technology to support cosmetic, medical, wellness, and regenerative applications across the healthcare and beautyindustries. | $227.9K / Venture - Series Unknown / Jul 01, 2023 | ||
| Eastech is a company that specializes in the research and development of drug substance candidates using 3D structural information analysis. | Seed / Nov 17, 2022 | ||
| Cigro provides a data integration solution for e-commerce operators. | Seed / Aug 16, 2022 | ||
| SOS Lab, a LiDAR development company focusing on core technology for self-driving cars, plans to present its differentiated hybrid LiDAR system, the SL-1SOS LAB's long-range, hybrid scanning design combines the advantages of the widely-used motor scanning system with a solid-state MEMS mirror, and will be offered at a much lower price pointcompared to traditional LiDAR products on the market today. SL-1 is expected to play an important role in the popularization and accessibility of self-driving cars.In addition to the SL-1, SOS LAB offers two additional LiDAR products designed to integrate safe, effective, and affordable LiDAR technology into various industries: the GL-3 for factory automation and robotics, and the TL-3 for security and automatic doors. SOS LAB is also focusing on combining hardware-based sensors and AI-based object recognition and tracking technology using 3D point cloud LiDAR data, and plans to provide LiDAR data space/object recognition solutions for self-driving vehicles.SOS LAB includes jointly developing their hybrid LiDAR with a partner automotive electronic equipment field company, continuing to develop the next generation of Solid-State-LiDAR with global semiconductor companies to overstep the limits of OPA-method LiDAR, and extending the global footprint of SOS LAB to provide the smartest solutions for self-driving and ADAS markets. SOS LAB is planning to enter global markets based on its R&D centers in Seoul and Gwangju and business centers in Silicon Valley. | $14.8M / Series B / Jul 27, 2022 | ||
| LyseNTech is a bacteriophage company that develops antibiotic-resistant bacteria. | $8.2M / Series A / Dec 22, 2021 | ||
| Study Senior provides educational assistance and O2O (online to offline) platform . | $9M / Series B / Jun 15, 2021 | ||
| The Larchive is the most powerful, flexible tool for supply chain professionals who need real-time data and analytics. Simplos identifies supply chain risks to keep the world moving. Global supply chains have a structure vulnerable to various external shocks, posing a risk of disruption due to unexpected issues. Therefore, we utilize deeplearning-based market sensing technology to monitor factors affecting import and export supply chains 24/7 and, through predictive analytics, enable companies to proactively respond to risks. | Angel / May 31, 2021 | ||
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Synergy IB Investment invest in?
Synergy IB Investment invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Seed and Series B stage. Most of the 18 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Synergy IB Investment's check size?
Synergy IB Investment typically joins rounds of $6.2M–$8.9M at Series A and $12k–$15M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Synergy IB Investment participates in.
How do I contact Synergy IB Investment?
Public channels for Synergy IB Investment include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Synergy IB Investment?
The team at Synergy IB Investment includes Jeong Ahn-sik (CEO) and tae-hoon Koo (Kurt) (Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
